Cyclooxygenase-2 Inhibitors - Index

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

• Revision history
  • July 21, 2023
  • July 23, 2021
  • July 2019
  • May 2019
  • May 2016
  • Oct. 2014
  • Feb. 2013
  • Dec. 2012
  • March 2011
  • Jan. 2011
  • Oct. 2007
  • Feb. 2006
  • Jan. 2006
  • Jan. 2004
  • Jan. 2003
• Initially developed
  • Jan. 2002